[Immunological disturbances in psoriatic patients exposed to radionuclides and corrective complex therapy with dibazol and hepatoradioprotective diet].
In an inpatient setting, 67 and 70 patients with psoriasis living in contaminated and uncontaminated with radionuclides territories respectively were studied in the time-related course of some qualitative indices of immunity. Significant deviations from the norm were recordable, especially in those patients residing in the contaminated with radionuclides tcrritiry. Combined treatment involving the use of dibazol and hepatoradioprotective diet in the experiment group of psoriatic patients proved to be significantly more effective than in patients of the control group who were treated by the generally accepted method.
S V
SV
Skliarov
I N
IN
Liashenko
V I
VI
Skliarov
S A
SA
Bondar
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000528:radiation effects; D001562:Benzimidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D003131:Combined Modality Therapy; D004035:Diet Therapy / Q000379:methods; D018565:Food-Drug Interactions; D006801:Humans; D008875:Middle Aged; D011565:Psoriasis / Q000178:diet therapy / Q000188:drug therapy / Q000276:immunology; D011848:Radioactive Pollutants / Q000009:adverse effects*; D011868:Radioisotopes; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000528:radiation effects; D016896:Treatment Outcome; D014455:Ukraine
D000276:Adjuvants, Immunologic; D001562:Benzimidazoles; D011848:Radioactive Pollutants; D011868:Radioisotopes; C004453:bendazole